Invesco Nasdaq Biotechnology ETF Rating $32.68 +0.02 (+0.06%) As of 04:00 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsTrendsBuy This Stock Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy 2.72Holdings in IBBQ have an aggregate rating of Moderate Buy based on 522 analyst ratings issued in the past year covering 25 companies (60.0% of the portfolio).IBBQ Aggregate Price Target$32.57-0.34% DownsideHigh Prediction$32.57Average Prediction$32.57Low Prediction$32.57Holdings in IBBQ have an aggregate price target of $32.57 and a range of $32.57 to $32.57 covering 25 companies (60.0% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBBQ Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.41%VRTXVertex Pharmaceuticals$498.01+0.3%3.9679 of 5 stars2.88$555.91 11.6%25Positive NewsAnalyst DowngradeInsider Trade7.09%AMGNAmgen$361.33-0.2%3.5315 of 5 stars2.43$355.50 -1.6%30Trending NewsAnalyst Forecast6.77%GILDGilead Sciences$125.97-0.3%4.9829 of 5 stars2.86$158.41 25.8%29Positive NewsAnalyst Revision5.02%REGNRegeneron Pharmaceuticals$624.72+0.2%4.9052 of 5 stars2.73$792.65 26.9%26Positive News2.92%ALNYAlnylam Pharmaceuticals$301.67+0.2%4.4241 of 5 stars2.85$461.39 52.9%26Trending NewsAnalyst UpgradeAnalyst Revision2.56%RVMDRevolution Medicines$187.51+0.1%1.7003 of 5 stars3.00$134.50 -28.3%22Analyst Forecast2.29%BIIBBiogen$209.74-2.9%3.3913 of 5 stars2.52$217.41 3.7%31Analyst Forecast2.00%MRNAModerna$72.50+3.5%1.1187 of 5 stars1.83$37.13 -48.8%181.98%ARGXargenex$909.50-2.0%4.107 of 5 stars2.92$1,023.39 12.5%241.96%ILMNIllumina$183.89+4.6%2.2175 of 5 stars2.32$148.94 -19.0%19Analyst Forecast1.86%UTHRUnited Therapeutics$547.15+1.0%4.5636 of 5 stars2.85$619.42 13.2%13Insider Trade1.80%RPRXRoyalty Pharma$55.78-0.5%4.2972 of 5 stars3.00$53.71 -3.7%71.78%ROIVRoivant Sciences$35.04-1.0%1.8317 of 5 stars2.75$33.59 -4.1%12News CoverageInsider Trade1.64%INSMInsmed$107.00+0.4%3.7594 of 5 stars2.96$211.86 98.0%25Positive News1.55%INCYIncyte$113.81+0.4%3.774 of 5 stars2.36$107.85 -5.2%22Analyst Forecast1.40%VTRSViatris$16.18+1.9%2.7271 of 5 stars2.57$17.50 8.2%71.37%GHGuardant Health$170.77+13.8%1.9113 of 5 stars3.00$146.18 -14.4%24Analyst ForecastInsider TradeGap UpHigh Trading Volume1.26%NBIXNeurocrine Biosciences$167.77-0.5%4.5657 of 5 stars2.96$187.52 11.8%23Insider Trade1.13%ASNDAscendis Pharma A/S$267.79+0.4%4.2797 of 5 stars3.00$295.39 10.3%19Positive News1.10%JAZZJazz Pharmaceuticals$237.51-1.4%3.2712 of 5 stars2.84$246.06 3.6%19Positive NewsAnalyst Upgrade1.07%EXELExelixis$53.96-0.8%2.5316 of 5 stars2.30$46.87 -13.1%20Positive News1.04%MEDPMedpace$543.57+2.6%2.007 of 5 stars2.20$467.08 -14.1%15Gap Up1.02%AXSMAxsome Therapeutics$240.66-1.7%2.1046 of 5 stars2.95$258.95 7.6%211.02%BBIOBridgeBio Pharma$74.52+0.1%3.2181 of 5 stars2.83$92.90 24.7%240.97%IONSIonis Pharmaceuticals$79.19-0.1%3.1442 of 5 stars2.90$102.90 29.9%21Insider TradeAnalyst Revision This page (NASDAQ:IBBQ) was last updated on 7/1/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredPorter flew 3,300 miles to investigate this systemPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredI paid $5,000 to hear Elon say thisOne investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
